Product Information
GALANTAMINE HBR 8 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.4371 per EA under NDC 70436000506. Its NADAC has been published 381 times since Jan 31, 2018.
FDA first approved this application on Feb 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436000506
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077604FDA Approved
2/6/2009
TE Code
AB
On Market Since
8/2/2017
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 8 MG TABLET has been published 381 times since Jan 31, 2018, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4371 per EA |
|---|---|
| All-time high | $1.1958 (Feb 14, 2018) |
| All-time low | $0.3390 (Jan 22, 2025) |
| Median price | $0.5260 |
| Average price | $0.5492 |
| Largest weekly change | +57.2% (Jun 20, 2018) |
| Weeks tracked | 381 |
| Tracking since | Jan 31, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+6.2%
5Y
-19.5%
All
-63.4%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
galantamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 8 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.4371 per EA (NDC 70436000506), effective May 14, 2025.
How has the price of GALANTAMINE HBR 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 8 MG TABLET has declined 63.4%. It has been tracked across 381 weekly CMS publications since Jan 31, 2018.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 8 MG TABLET?
Since Jan 31, 2018, the NADAC for GALANTAMINE HBR 8 MG TABLET has ranged from a low of $0.3390 (Jan 22, 2025) to a high of $1.1958 (Feb 14, 2018), with a median of $0.5260 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 8 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GALANTAMINE HBR 8 MG TABLET, is $0.4017 per EA — about 8% below GALANTAMINE HBR 8 MG TABLET.
Who manufactures GALANTAMINE HBR 8 MG TABLET?
GALANTAMINE HBR 8 MG TABLET (NDC 70436000506) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.